-
Technical preparation of glutathione liposomes for food applications
Glutathione (GSH) is a tripeptide that can be naturally synthesized by human cells, composed of glutamic acid, cystine and glycine.
View -
Self-description of upgraded Version of Glutathione - S-Acetyl-L-Glutathione
True friendship comes from a sincere self-introduction. I would like to introduce myself to you all with great honor: I am S-acetyl-L-glutathione, and I have a close genetic relationship with glutathione.
View -
Glutathione is unsung hero of human body, from antioxidation to cellular protection
L-Glutathione is hailed as the mother of antioxidants and plays a crucial role in maintaining human health.
View -
Summary of basic research literature on glutathione
Glutathione (GSH) : Glutathione is widely present in animals and plants, and its content is very high in baker's yeast and wheat germ.
View -
synthesis of glutathione and its role in abiotic stress in plants
development of a new method for preparing compounds in crystalline form confirmed that glutathione is indeed a tripeptide of glutamic acid, cysteine and glycine.
View -
Here's what you need to know about glutathione
Glutathione is ubiquitous in the human body and acts as a natural reducing agent. It is easily oxidized into GSSG, thereby protecting other substances from oxidation.
View -
competitive landscape of glutathione industry is fierce
The competition pattern of China's glutathione industry is relatively fierce, and the government's policy support for the glutathione industry is gradually increasing
View -
Spring liver nourishing golden period, these liver nourishing point quick collection
Spring is the season for all things to recover, and it is also a key period for human metabolism to accelerate and liver function to be active.
View -
Reduced Glutathione of Effect and function
Reduced glutathione: multifaceted guardian of human health In this complex and delicate system of the human body, there is a substance that silently guards our health, and it is reduced glutathione.
View -
FDA to adjust CAR-T cell therapy for secondary cancer black box warning
In light of the latest developments, the U.S. Food and Drug Administration (FDA) is planning to revise the secondary malignancy risk warning for CAR-T cell therapy based on the latest safety data. At
View
News
